In order to provide clinicians with predicted prognosis of LGG patients quantitatively, we constructed the nomogram combining HOXA1, HOXA6 expression and independent clinical risk factors (tumor grade, age, primary therapy outcome and age). The gene discussed is HOXA6; the disease is neoplasm.